Cardiopulmonary Exercise Testing Contributes to Accurate Risk Assessment in Patients with Low-risk Pulmonary Hypertension

pp. 130-134

Authors

  • Ignacio M. Bluro Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. https://orcid.org/0000-0003-1833-6090
  • Leandro Barbagelata Hospital Italiano de Buenos Aires, Buenos Aires, Argentina https://orcid.org/0000-0003-3694-1083
  • María Lorena Coronel Instituto de Cardiología de Corrientes “Juana F. Cabral”, Corrientes, Argentina
  • Lucio Melatini Instituto de Neumonología del Sur, Bahía Blanca, Argentina
  • Graciela Svetliza Hospital Italiano de Buenos Aires, Buenos Aires, Argentina https://orcid.org/0000-0001-8817-5240
  • Norberto Vulcano Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Andrés N. Atamañuk Hospital Juan A. Fernández, Buenos Aires, Argentina.
  • Walter M. Masson Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
  • Rodolfo Pizarro Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

DOI:

https://doi.org/10.7775/rac.es.v91.i2.20613

Keywords:

Hypertension, Pulmonary, Risk Assessment, Oxygen Consumption, Exercise Tolerance, Exercise Test

Abstract

Background: European guidelines for pulmonary arterial hypertension (PAH) stratify the risk using clinical characteristics and complementary studies, including the cardiopulmonary exercise test (CPET). This takes into account 3 parameters: peak O2 con-sumption (peak VO2), its percentage with respect to the predicted VO2, and the minute ventilation/carbon dioxide production (VE/VCO2) slope. However, none of the models that validated this way of stratifying risk included PCPE among their variables.

Objectives: To determine what proportion of patients with group I PAH considered to be at low risk and who walk >440 meters in the 6-minute walk test (6MWT) have parameters considered to be of moderate or high risk in the PCPE.

Methods: Patients >18 years of age, diagnosed with group I PAH at low risk of events, who walked >440 meters in the 6MWT and had NT-proBNP value < 300 pg/dL were included. A CPET was performed in which the peak VO2, its percentage with respect to the predicted VO2, and the VE/VCO2 slope were recorded. It was determined what proportion of patients presented these parameters in a higher than low risk stratum (peak VO2 consumption ≤15 ml/min/Kg, its percentage with respect to the predicted VO2≤65% and the VE/VCO2 slope ≥ 36).Results: Eighteen patients were included. Despite being low-risk patients with a good functional class, all patients presented a peak VO2 less than 85% of predicted, which determines a deterioration of functional capacity. A single patient (6%) presented the three parameters evaluated at low risk, 8 patients (44%) had at least one altered parameter, 7 patients (39%) presented 2 altered param-eters and in 2 patients (11%) all parameters were altered. The parameters that were most frequently altered were the percentage of predicted peak VO2 and the VE/VCO2 slope in 67% of the cases. Only 4 patients presented a peak VO2 <15 ml/kg/m. No patient presented peak VO2 values or percentage of predicted VO2 in the high-risk category. However, 6 patients (33%) presented a high-risk VE/VCO2 slope.

Conclusion: Majority (92%) of the patients considered low risk and who walk more than 440 meters in 6 minutes presented at least one altered variable in the CPET. The VE/VCO2 slope and the percentage of predicted peak VO2 consumption were the most fre-quently altered variables. The VE/VCO2 slope was the only one...

How to cite this article:

Bluro I, Barbagelata L, Coronel M, Melatini L, Svetliza G, Vulcano N, et al. Cardiopulmonary Exercise Testing Contributes to Accurate Risk Assessment in Patients with Low-risk Pulmonary Hypertension. Rev Argent Cardiol 2023;91:130-4
https://doi.org/10.7775/rac.es.v91.i2.20613

Published

2023-05-15

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)

1 2 3 4 5 6 > >>